Boots is selling a 32p pill that has been shown to reduce high cholesterol and help maintain healthy levels. According to the ...

Cholesterol: A Hidden Threat That’s Hard to Tame In France, more than one in five adults lives with high cholesterol, ...

New findings show favorable treatment continuity for UZEDY compared to other long-acting injectables in schizophrenia, as ...

When I tried statin therapy as part of an experiment, I quickly developed a common side effect. But what concerned me wasn’t ...

First-line treatment with amivantamab plus lazertinib maintains clinically meaningful and durable antitumor efficacy in ...

WSJ Buy Side is The Wall Street Journal’s research and commerce team. Our commerce content is distinct from our newsroom coverage. We earn a commission from some links in our articles. Learn more.

Long-term ADAURA data showed sustained OS benefits with osimertinib in patients with resected EGFR-mutated NSCLC.

A major change is the adoption of the PREVENT-ASCVD equations, which estimate both 10-year and 30-year cardiovascular risk ...

Patients who receive a longer initial Z-drug prescription are more likely to fill additional prescriptions after the index ...

Takeda (TSE:4502/NYSE:TAK) announced that the New England Journal of Medicine published results from two Phase 3 studies ...

The cholesterol-busting drugs are more effective the earlier in life they are taken, 15-year research project indicates Statins can lower the risk of dementia by 15%, and the earlier in life they are ...

Polo Rocha has written about economics and banking for a decade. Michael Nagle / Bloomberg via Getty Images The U.S. Treasury is buying back long-term bonds to ease rising yields. The yield on 30-year ...